Opioid addicts covered by Medicare and Medicaid are less likely to receive the mental health and substance use treatment that they need, a new study says.

The growing global burden of neuropsychiatric disorders is a critical driver for the treatment market. With over 9.1 million annual deaths attributed to neurological diseases and an additional 8 ...

There is new evidence suggesting therapy may lead to higher recovery rates than medication in people over 60 who experience ...

Bilateral stimulation is the use of visual, auditory, or tactile external stimuli occurring in a rhythmic side-to-side ...

TUESDAY, July 1, 2025 (HealthDay News) — Opioid addicts covered by Medicare and Medicaid are less likely to receive the ...

Autoimmune diseases, especially in women, are associated with nearly a twofold increased risk for affective disorders, new ...

Researchers found that MDMA reduces anxiety and enhances social behavior in zebrafish by altering key neurochemical systems.

While the stress of everyday life – including work, relationships, housing issues, caregiving responsibilities and financial ...

Anxiety, the psychological and physiological state characterized by an anticipation of potential threats and a heightened ...

A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New ...

Generalized anxiety disorder (GAD) affects some 6.8 million adults in the United States, though less than half of them are receiving treatment. Chronic worry interferes with an ability to function ...

Anxiety disorders are one of the most common mental disorders. Learn about the types of anxiety, and their ... including a rapid heart rate, blushing, trembling, feeling their mind go blank and nausea ...